The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer | European Respiratory Society
Mechanisms of resistance to EGFR tyrosine kinase inhibitors - ScienceDirect
A) Erlotinib bound to the epidermal growth factor receptor (EGFR)... | Download Scientific Diagram
Erlotinib Tarceva Dosage & Uses, Side Effects and Treatment Medication by asukaccp - issuu
Combination Treatment with Erlotinib and Pertuzumab against Human Tumor Xenografts Is Superior to Monotherapy | Clinical Cancer Research
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer | Signal Transduction and Targeted Therapy
Identification of Ketene-Reactive Intermediate of Erlotinib Possibly Responsible for Inactivation of P450 Enzymes | Drug Metabolism & Disposition
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer | PGPM
Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer | Clinical Cancer Research
InOncology - Afatinib NSCLC Treatment | Information | Boehringer Ingelheim
Erlotinib | SpringerLink
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer | Clinical Cancer Research
Cancers | Free Full-Text | Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment | HTML
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pha
Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/ erlotinib and to ALK inhibitor crizotinib - Lung Cancer
a) Mechanism of action of temozolomide. (b) The mechanism of erlotinib... | Download Scientific Diagram
Mechanism of acquired T790m mutation and action of 3rd generation EGFR... | Download Scientific Diagram
Figure 1 from Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cells. | Semantic Scholar
Erlotinib - Drugs Details
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer - Lung Cancer
Mechanisms of acquired resistance to gefitinib/erlotinib in... | Download Scientific Diagram
Mechanisms of resistance to EGFR tyrosine kinase inhibitors - ScienceDirect
Afatinib mechanism of action. Notes: From Hirsh, 45 with permission.... | Download Scientific Diagram
Frontiers | EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies | Oncology
